Serial Number
79337464
Owner
SCT CELL MANUFACTURING S.R.O.Attorney
Shane RumbaughFiling Date
Feb 9, 2022
SCTBIO Trademark
Serial Number: 79337464 • Registration: 7435168
Trademark Classes
Owner Contact Info
JANKOVCOVA 1518/2
CZ-170 00 PRAGUE 7 , CZ
Entity Type: 99
Legal Representation
Correspondence Address
Shane Rumbaugh Steptoe & Johnson PLLC
One PPG Place, Suite 3300
Pittsburgh, PA 15222
UNITED STATES
Trademark Details
Filing Date
February 9, 2022
Registration Date
July 9, 2024
Published for Opposition
April 23, 2024
Goods & Services
Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals, to the order and specification of others
Labeling, relabeling, storage and distribution of cell therapy materials
Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; product research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies
